| Carvedilol |
II-15914/29.12.2006 |
Avernol 25 mg, Tablet, 25, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
2.95 |
0.59 |
3.54 |
7% |
0.21 |
3.16 |
0.63 |
3.79 |
20% |
0.59 |
3.75 |
0.75 |
4.5 |
|
НСР-1968/06.12.2013 |
27.12.2013 |
27.12.2013 |
Неактивен |
3118 |
| Carvedilol |
II-15914/29.12.2006 |
Avernol 25 mg, Tablet, 25, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
7.57 |
1.51 |
9.08 |
7% |
0.53 |
8.1 |
1.62 |
9.72 |
20% |
1.51 |
9.61 |
1.92 |
11.53 |
|
КЦ-494/04.02.2009 |
24.02.2009 |
24.02.2009 |
Неактивен |
3118 |
| Carvedilol |
20060879 |
Avernol 6.25 mg, Tablet, 6.25, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
1.56 |
0.31 |
1.87 |
7% |
0.11 |
1.67 |
0.33 |
2 |
20% |
0.31 |
1.98 |
0.4 |
2.38 |
|
НСР-4312/05.08.2014 |
20.08.2014 |
20.08.2014 |
Активен |
3117 |
| Carvedilol |
II-15913/ 29.12.2006 г. |
Avernol 6.25 mg, Tablet, 6.25, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
1.66 |
0.33 |
1.99 |
7% |
0.12 |
1.78 |
0.36 |
2.14 |
20% |
0.33 |
2.11 |
0.42 |
2.53 |
|
НСР-1968/06.12.2013 |
27.12.2013 |
27.12.2013 |
Неактивен |
3117 |
| Carvedilol |
II-15913/ 29.12.2006 г. |
Avernol 6.25 mg, Tablet, 6.25, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
3.11 |
0.62 |
3.73 |
7% |
0.22 |
3.33 |
0.67 |
4 |
20% |
0.62 |
3.95 |
0.79 |
4.74 |
|
КЦ-494/04.02.2009 |
24.02.2009 |
24.02.2009 |
Неактивен |
3117 |
| Dutasteride |
II-8674 / 08.03.2004 г. |
Avodart, Capsule, soft, 0.5, mg, Pack: 30 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmith Kline Pharmaceuticals S.A. Poland, Aspen Bad Oldesloe GmbH, Germany |
29.63 |
5.93 |
35.56 |
6% |
1.78 |
31.41 |
6.28 |
37.69 |
18% |
5.33 |
36.74 |
7.35 |
44.09 |
КЦPP-2260/11.02.2013 за промяна на обстоятелства; Цената е вписана в регистъра на пределените цени с решение НСР-1491/21.10.2013 |
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Заличен |
134 |
| Interferon beta-1a |
ЕU/1/97/033/003 |
Avonex, Solution for injection, 30 mcg/0.5 ml (6MIU), -, Pack: 4 pre-filled syringes + 4 needles |
Biogen Idec Limited, Германия |
Biogen Idec Denmark Manufacturing |
1243.42 |
248.68 |
1492.1 |
4% |
10 |
1253.42 |
250.68 |
1504.1 |
16% |
25 |
1278.42 |
255.68 |
1534.1 |
корекц. Решение НСР-5352/18.12.2014; Протокол 101/29.01.2015 ; промяна обстоятелства НСР-6158/29.04.2015 |
НСР-4294/05.08.2014 |
20.08.2014 |
20.08.2014 |
Активен |
3138 |
| Interferon beta-1a |
ЕU/1/97/033/003 |
Avonex, Solution for injection, 30 mcg/0.5 ml (6MIU), mcg, Pack: 4 |
Biogen Idec Limited, Германия |
Biogen Idec BV, Холандия; Biogen Idec Denmark Manufacturing |
1310.74 |
262.15 |
1572.89 |
4% |
10 |
1320.74 |
264.15 |
1584.89 |
16% |
25 |
1345.74 |
269.15 |
1614.89 |
|
НСР-1890/27.11.2013 |
13.12.2013 |
13.12.2013 |
Неактивен |
3138 |
| Interferon beta-1a |
ЕU/1/97/033/003 |
Avonex, Solution for injection, 30 mcg/0.5 ml (6MIU), mcg, Pack: 4 |
Biogen Idec Limited, Германия |
Biogen Idec BV, Холандия; Biogen Idec Denmark Manufacturing |
1393 |
278.6 |
1671.6 |
4% |
10 |
1403 |
280.6 |
1683.6 |
16% |
25 |
1428 |
285.6 |
1713.6 |
|
КЦРР-1196/13.08.2012 |
11.09.2012 |
11.09.2012 |
Неактивен |
3138 |
| Interferon beta-1a |
EU/1/97/033/002 |
AVONEX 30 mcg (6 MIU), Powder and solvent for solution for injection, 30, mcg, Pack: 4 |
Biogen Idec Limited, Германия |
Biogen Idec- the Netherlands |
1101.39 |
220.28 |
1321.67 |
4% |
10 |
1111.39 |
222.28 |
1333.67 |
16% |
25 |
1136.39 |
227.28 |
1363.67 |
цената се заличава КЦРР-1682/20.11.2012 |
КЦРР-1182/07.08.2012 |
14.09.2012 |
14.09.2012 |
Заличен |
1349 |
| Interferon beta-1a |
EU/1/97/033/002 |
AVONEX 30 mcg (6 MIU), Powder and solvent for solution for injection, 30, mcg, Pack: 4 |
BioMarin Europe Limited, Обединено Кралство |
Biogen Idec- the Netherlands |
1402.7 |
280.54 |
1683.24 |
4% |
10 |
1412.7 |
282.54 |
1695.24 |
16% |
25 |
1437.7 |
287.54 |
1725.24 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
1349 |
| Cefuroxime |
20011073 |
AXETINE, Powder for solution for injection/infusion, 750, mg, Pack: 10 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
10.56 |
2.11 |
12.67 |
6% |
0.63 |
11.19 |
2.24 |
13.43 |
18% |
1.9 |
13.09 |
2.62 |
15.71 |
|
НСР-3145/26.03.2014; НСР-9679/30.06.2016 |
02.08.2016 |
02.08.2016 |
Активен |
2632 |
| Cefuroxime |
II-8672/08.03. 2004 |
AXETINE 1,5 G, Powder for solution for injection, 1500, mg, Pack: 100 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
190.26 |
38.05 |
228.31 |
4% |
7.61 |
197.87 |
39.57 |
237.44 |
16% |
25 |
222.87 |
44.57 |
267.44 |
|
КЦРР-859/21.06.2012; НСР-10427/29.09.2016 |
02.11.2016 |
02.11.2016 |
Активен |
1276 |
| Cefuroxime |
II-8672/08.03. 2004 |
AXETINE 1,5 G, Powder for solution for injection, 1500, mg, Pack: 100 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
244.3 |
48.86 |
293.16 |
4% |
9.77 |
254.07 |
50.81 |
304.88 |
16% |
25 |
279.07 |
55.81 |
334.88 |
|
КЦРР-859/21.06.2012 |
06.07.2012 |
06.07.2012 |
Неактивен |
1276 |
| Cefuroxime |
II-8672/08.03. 2004 |
AXETINE 1,5 G, Powder for solution for injection, 1500, mg, Pack: 100 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
606.31 |
121.26 |
727.57 |
6% |
15 |
621.31 |
124.26 |
745.57 |
18% |
30 |
651.31 |
130.26 |
781.57 |
|
КЦ-494/04.02.2009 |
24.02.2009 |
24.02.2009 |
Неактивен |
1276 |
| Cefuroxime |
20011073 |
AXETINE 750 MG, Powder for solution for injection, 750, mg, Pack: 10 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
19.56 |
3.91 |
23.47 |
6% |
1.17 |
20.73 |
4.15 |
24.88 |
18% |
3.52 |
24.25 |
4.85 |
29.1 |
|
НСР-3145/26.03.2014 |
10.04.2014 |
10.04.2014 |
Неактивен |
2632 |
| Cefuroxime |
II-15229/13.12.2006 |
AXETINE 750 MG, Powder for solution for injection, 750, mg, Pack: 10 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
20.15 |
4.03 |
24.18 |
6% |
1.21 |
21.36 |
4.27 |
25.63 |
18% |
3.63 |
24.99 |
5 |
29.99 |
|
КЦ-494/04.02.2009 |
24.02.2009 |
24.02.2009 |
Неактивен |
2632 |
| Nizatidine |
II-12191/17.01.2006 |
AXID, Concentrate for solution for infusion, 25 mg/ml-4ml, -, Pack: 5 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачествените Лекарства АД, гр. София |
10.28 |
2.06 |
12.34 |
6% |
0.62 |
10.9 |
2.18 |
13.08 |
18% |
1.85 |
12.75 |
2.55 |
15.3 |
промяна на обстоятелства решение КЦ-798/07.04.2009; КЦPP-581/04.05.2012 |
КЦ-165/04.08.2008 |
28.08.2008 |
28.08.2008 |
Активен |
79 |
| Memantine |
EU/1/02/218/007 |
Axura, Film coated tablet, 10, mg, Pack: 28 |
Merz Pharmaceuticals GmbH, Германия |
Merz Pharma GmbH & Co. KGaA - Германия |
39.7 |
7.94 |
47.64 |
4% |
1.59 |
41.29 |
8.26 |
49.55 |
16% |
6.35 |
47.64 |
9.53 |
57.17 |
Цената се вписва в регистъра на пределните цени с решение НСР-6364/03.06.2015( в сила от 02.07.2015). |
НСР-3702/06.06.2014 |
23.06.2014 |
23.06.2014 |
Заличен |
2915 |
| Memantine |
EU/1/02/218/007 |
Axura, Film coated tablet, 10, mg, Pack: 28 |
Merz Pharmaceuticals GmbH, Германия |
Merz Pharma GmbH & Co. KGaA - Германия |
67.81 |
13.56 |
81.37 |
4% |
2.71 |
70.52 |
14.1 |
84.62 |
16% |
10.85 |
81.37 |
16.27 |
97.64 |
|
НСР-316/03.07.2013 |
02.09.2013 |
02.09.2013 |
Неактивен |
2915 |
| Memantine |
EU/1/02/218/007 |
Axura, Film coated tablet, 10, mg, Pack: 28 |
Merz Pharmaceuticals GmbH, Германия |
Merz Pharma GmbH & Co. KGaA - Германия |
69.55 |
13.91 |
83.46 |
4% |
2.78 |
72.33 |
14.47 |
86.8 |
16% |
11.13 |
83.46 |
16.69 |
100.15 |
|
КЦРР-1291/21.08.2012 |
24.09.2012 |
24.09.2012 |
Неактивен |
2915 |
| Memantine |
EU/1/02/218/007 |
Axura, Film coated tablet, 10, mg, Pack: 28 |
Merz Pharmaceuticals GmbH, Германия |
Merz Pharma GmbH & Co. KGaA - Германия |
75.18 |
15.04 |
90.22 |
4% |
3.01 |
78.19 |
15.64 |
93.83 |
16% |
12.03 |
90.22 |
18.04 |
108.26 |
|
КЦ-1676/25.06.2010 |
19.07.2010 |
19.07.2010 |
Неактивен |
2915 |
| Aztreonam |
II-8438/5.1.2004 |
AZACTAM, Powder for solution for injection, 1, g, Pack: 1 |
Bristol-Myers Squibb Kft, Унгария |
Bristol-Myers Squibb S.p.A., via del Morillo, 04019 Sermoneta, Anagni, Italy |
15.14 |
3.03 |
18.17 |
6% |
0.91 |
16.05 |
3.21 |
19.26 |
18% |
2.73 |
18.78 |
3.76 |
22.54 |
цената е заличена с решение КЦРР-1536/25.10.2012 |
КЦРР-790/15.06.2012 |
07.08.2012 |
07.08.2012 |
Заличен |
1251 |
| Aztreonam |
II-8438/05.01.2004 |
AZACTAM, Powder for solution for injection, 1, g, Pack: 1 |
Bristol-Myers Squibb Kft, Унгария |
Bristol-Myers Squibb S.p.A., via del Morillo, 04019 Sermoneta, Anagni, Italy |
18.58 |
3.72 |
22.3 |
8% |
1.49 |
20.07 |
4.01 |
24.08 |
20% |
3.72 |
23.79 |
4.76 |
28.55 |
|
КЦ-497/04.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
1251 |
| Brinzolamide, Timolol |
EU/1/08/482/001 |
Azarga, Eye drops, suspension, 10 mg/ml +5 mg/ml - 5 ml, mg, Pack: 1 bottle |
Alcon Laboratories (UK) Ltd., Обединено Кралство |
S.A. Alcon Couvreur N.V., Белгия |
17.23 |
3.45 |
20.68 |
6% |
1.03 |
18.26 |
3.65 |
21.91 |
18% |
3.1 |
21.36 |
4.27 |
25.63 |
|
НСР-4588/15.09.2014 |
30.09.2014 |
30.09.2014 |
Неактивен |
3187 |